A $600 million patent licensing dispute over the use of Botox to treat migraine headaches has been resolved in Allergan PLC’s favor with a U.S. judge scolding Miotox LLC for making “tedious and convoluted” arguments to prove its case.
top of page
Search
Recent Posts
See AllGeneral Motors has secured an Indian patent on a hybrid powertrain control system for vehicles. The patent rights are currently assigned...
Taking into consideration the Delhi High court’s order staying the abandonment orders passed by the Trademarks Office, the Registrar of...
The order of the Delhi High Court allows the Competition Commission of India (CCI) to attend to complaints on abuse of dominance of...
bottom of page
ความคิดเห็น